Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvo save search
Global Insulin Pen Market Projected to Reach $73.39 Billion by 2028 with Steady CAGR of 5.25% during 2023-2028
Published: 2023-07-28 (Crawled : 19:00) - prnewswire.com
TRUMY | $16.507 0.79% 34K
|
Manufacturing
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
reach global insulin market
The Worldwide Generic Drugs Market is Expected to Grow at a CAGR of over 6.51% During 2018-2028
Published: 2023-07-28 (Crawled : 02:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.63%
H: 2.59%
C: 1.75%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: -0.48%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.01%
H: 0.93%
C: 0.75%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.36%
H: 0.09%
C: -0.02%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -1.09%
H: 0.3%
C: -0.4%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.09%
H: 0.0%
C: 0.0%
expected market
Novo Nordisk A/S - share repurchase programme
Published: 2023-07-24 (Crawled : 13:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.14%
H: 0.1%
C: -1.04%
repurchase
Diabetic Peripheral Neuropathy Market Growing at a CAGR of ~6% by 2032 | DelveInsight
Published: 2023-07-20 (Crawled : 21:00) - prnewswire.com
BMEA | $10.87 -2.6% -2.67% 1.3M
|
Professional, Scientific, and T...
|
| O: 0.71%
H: 3.64%
C: 0.61%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.16%
H: 1.18%
C: 0.88%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.34%
H: 0.35%
C: -0.72%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.86%
H: 0.57%
C: -0.68%
APLT A | $4.4 -7.17% -7.73% 2.9M
|
Health Technology
|
| O: 1.46%
H: 6.12%
C: 2.88%
ALT | $6.91 0.29% 0.29% 3.6M
|
Commercial Services
|
| O: 1.57%
H: 0.0%
C: -2.79%
growing market diabetic
Novo Nordisk A/S - share repurchase programme
Published: 2023-07-17 (Crawled : 13:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.91%
H: 0.15%
C: -0.4%
repurchase
Global Nicotinamide Adenine Dinucleotide Market to Reach $1,722.11 Million by 2032: Increasing Product Penetration Drives Growth
Published: 2023-07-14 (Crawled : 23:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
reach global growth market
Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight
Published: 2023-07-12 (Crawled : 21:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.7%
H: 0.01%
C: -0.32%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.08%
H: 0.46%
C: -1.26%
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 0.41%
H: 3.34%
C: 1.43%
LPCN | $5.33 -2.02% -2.06% 11K
|
Health Technology
|
| O: 0.11%
H: 2.15%
C: 1.02%
GALT | $3.37 -0.3% -0.3% 210K
|
Health Technology
|
| O: 0.64%
H: 7.01%
C: 5.1%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: 0.69%
H: 1.02%
C: 0.29%
AKRO | $20.76 1.22% 1.2% 790K
|
Health Technology
|
| O: 0.78%
H: 1.1%
C: -0.15%
cirrhosis liver growth market
Novo Nordisk A/S - share repurchase programme
Published: 2023-07-10 (Crawled : 13:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.39%
H: 0.66%
C: 0.45%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-07-03 (Crawled : 11:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.44%
repurchase
Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism
Published: 2023-06-30 (Crawled : 18:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.23%
H: 0.97%
C: 0.81%
fda pharma drug application
Rallybio Announces Succession Plan; Appoints Stephen Uden, M.D., as Chief Executive Officer, Effective August 1, 2023
Published: 2023-06-29 (Crawled : 12:20) - biospace.com/
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
RLYB | News | $1.75 4.79% 4.57% 310K
|
|
| O: -0.34%
H: 4.41%
C: -5.25%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.19%
H: 1.41%
C: 1.36%
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: 0.09%
H: 1.73%
C: 1.58%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan
Published: 2023-06-28 (Crawled : 02:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.47%
H: 0.0%
C: -0.94%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -2.09%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 6.1%
H: 5.34%
C: 0.82%
disease japan kidney market
Novo Nordisk A/S - share repurchase programme
Published: 2023-06-26 (Crawled : 12:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.25%
H: 0.29%
C: -1.41%
repurchase
Zealand Pharma Submits Marketing Authorization Application for Dasiglucagon for Treatment of Severe Hypoglycemia in Diabetes to the European Medicines Agency
Published: 2023-06-26 (Crawled : 07:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.25%
H: 0.29%
C: -1.41%
pharma authorization treatment hypoglycemia application diabetes
New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published: 2023-06-24 (Crawled : 00:20) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
trials diabetes insulin show
Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published: 2023-06-24 (Crawled : 00:20) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
trials diabetes insulin show
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published: 2023-06-22 (Crawled : 14:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
fda pancreas clearance insulin
Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL Behring, Freeline, Genentech, Shire, Spark, Novo Nordisk, Sangamo, UBI, uniQure
Published: 2023-06-21 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.44%
H: 1.6%
C: 0.59%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.73%
H: 0.09%
C: -0.6%
companies market
Novo Nordisk takes actions to help protect US patients from unlawful sales of non-FDA approved medicines claiming to contain semaglutide
Published: 2023-06-20 (Crawled : 15:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.0%
H: 1.9%
C: 1.25%
sales approved
Novo Nordisk A/S - share repurchase programme
Published: 2023-06-19 (Crawled : 12:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.